The end-organ impairment in liver cirrhosis: Appointments for critical care

Critical Care Research and Practice

Volumn 2012, Issue , 2012, Pages

  Figueiredo, Antonio ^a   Romero Bermejo, Francisco ^b   Perdigoto, Rui ^a   Marcelino, Paulo ^a,c  

^a HOSPITAL CURRY CABRAL   (Portugal)

^b HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^c UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866082166     PISSN: 20901305     EISSN: 20901313     Source Type: Journal    
DOI: 10.1155/2012/539412     Document Type: Review

References (102)

1. Sorensen H. T., Thulstrup A. M., Mellemkjar L., Jepsen P., Christensen E., Olsen J. H., Vilstrup H., Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. Journal of Clinical Epidemiology 2003 56 1 88 93 2-s2.0-0037268223 10.1016/S0895-4356(02)00531-0 (Pubitemid 36183320)
2. Schuppan D., Afdhal N. H., Liver cirrhosis. The Lancet 2008 371 9615 838 851 2-s2.0-40049097359 10.1016/S0140-6736(08)60383-9 (Pubitemid 351323895)
3. Volk M. L., Tocco R. S., Bazick J., Rakoski M. O., Lok A. S., Hospital readmissions among patients with decompensated cirrhosis. American Journal of Gastroenterology 2012 107 247 252 10.1038/ajg.2011.314
4. Fukumitsu K., Yagi H., Soto-Gutierrez A., Bioengineering in organ transplantation: targeting the liver. Transplantation Proceedings 2011 43 6 2137 2138
5. Barber K., Madden S., Allen J., Collett D., Neuberger J., Gimson A., United Kingdom liver transplant selection and allocation working party. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation 2011 92 4 469 476
6. Alqahtani S. A., Fouad T. R., Lee S. S., Cirrhotic cardiomyopathy. Seminars in Liver Disease 2008 28 1 59 69 2-s2.0-40149103833 10.1055/s-2008-1040321 (Pubitemid 351326533)
7. Uptodate, Diagnostic approach to the patient with cirrhosis., Uptodate, 2011
8. Vincent J. L., Gustot T., Sepsis and cirrhosis: many similarities. Acta Gastro-Enterologica Belgica 2010 73 4 472 478 2-s2.0-79952134883
9. Iwakiri Y., Groszmann R. J., The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006 43 2 S121 S131 2-s2.0-33644553509 10.1002/hep.20993
10. Lee S. S., Marty J., Mantz J., Samain E., Braillon A., Lebrec D., Desensitization of myocardial β -adrenergic receptors in cirrhotic rats. Hepatology 1990 12 3 481 485 2-s2.0-0025107464 (Pubitemid 20382015)
11. Ma Z., Meddings J. B., Lee S. S., Membrane physical properties determine cardiac β -adrenergic receptor function in cirrhotic rats. American Journal of Physiology 1994 267 1 G87 G93 2-s2.0-0028021582 (Pubitemid 24242587)
12. Manny A. R., Ippolito S., llosson R., Moore K. P., Nitration of cardiac proteins is associated with abnormal cardiac chronotropic responses in rats with biliary cirrhosis. Hepatology 2006 43 4 847 856 10.1002/hep.21115
13. Bátkai S., Járai Z., Wagner J. A., Goparaju S. K., Varga K., Liu J., Wang L., Mirshahi F., Khanolkar A. D., Makriyannis A., Urbaschek R., Garcia N., Sanyal A. J., Kunos G., Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nature Medicine 2001 7 7 827 832 2-s2.0-0034928628 10.1038/89953 (Pubitemid 32691638)
14. Kalambokis G., Korantzopoulos P., Nikas S. A., Theodorou A., Tsianos E. V., Significant improvement of portopulmonary hypertension after 1-week terlipressin treatment. Journal of Hepatology 2008 48 4 678 680 2-s2.0-39849087833 10.1016/j.jhep.2007.12.012
15. Pimenta J., Paulo C., Gomes A., Silva S., Rocha-Gonçalves F., Bettencourt P., B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis. Liver International 2010 30 7 1059 1066 2-s2.0-77957157909 10.1111/j.1478-3231.2010. 02266.x
16. Padillo J., Rioja P., Muñoz-Villanueva M. C., Vallejo J. A., Ciria R., Muntane J., Sitges-Serra A., Solórzano G., De La Mata M., BNP as marker of heart dysfunction in patients with liver cirrhosis. European Journal of Gastroenterology and Hepatology 2010 22 11 1331 1336 2-s2.0-78049234714 10.1097/MEG.0b013e32833e6b2a
17. Khan A. N., Al-Jahdali H., Abdullah K., Irion K. L., Sabih Q., Gouda A., Pulmonary vascular complications of chronic liver disease: pathophysiology, imaging, and treatment. Annals of Thoracic Medicine 2011 6 2 57 65 2-s2.0-79954540026 10.4103/1817-1737.78412
18. Krowka M. J., Cortese D. A., Hepatopulmonary syndrome: current concepts in diagnostic and therapeutic considerations. Chest 1994 105 5 1528 1537 2-s2.0-0028335620 (Pubitemid 24152616)
19. Kowalski H. J., Abelmann W. H., The cardiac output at rest in Laennec's cirrhosis. The Journal of Clinical Investigation 1953 32 10 1025 1033 2-s2.0-0000601905
20. Alqahtani S. A., Fuad T. R., Lee S. S., Cirrhotic Cardiomyopathy. Seminars in Liver Disease 2008 28 1 59 69 (Pubitemid 351326533)
21. Lee R. F., Glenn T. K., Lee S. S., Cardiac dysfunction in cirrhosis. Best Practice and Research 2007 21 1 125 140 2-s2.0-33846148983 10.1016/j.bpg.2006. 06.003 (Pubitemid 46075997)
22. Fouad T. R., Abdel-Razek W. M., Burak K. W., Bain V. G., Lee S. S., Prediction of cardiac complications after liver transplantation. Transplantation 2009 87 5 763 770 2-s2.0-65649098010 10.1097/TP.0b013e318198d734
23. Pozzi M., Redaelli E., Ratti L., Poli G., Guidi C., Milanese M., Calchera I., Mancia G., Time-course of diastolic dysfunction in different stages of chronic HCV related liver diseases. Minerva Gastroenterologica e Dietologica 2005 51 2 179 186 2-s2.0-26944446642 (Pubitemid 44251909)
24. Alexander J., Mishra P., Desai N., Ambadekar S., Gala B., Sawant P., Cirrhotic cardiomyopathy: Indian scenario. Journal of Gastroenterology and Hepatology 2007 22 3 395 399 2-s2.0-33846896221 10.1111/j.1440-1746.2006.04507.x (Pubitemid 46238771)
25. Milani A., Zaccaria R., Bombardieri G., Gasbarrini A., Pola P., Cirrhotic cardiomyopathy. Digestive and Liver Disease 2007 39 6 507 515 2-s2.0-34248530778 10.1016/j.dld.2006.12.014 (Pubitemid 46746640)
26. Wong F., Girgrah N., Graba J., Allidina Y., Liu P., Blendis L., The cardiac response to exercise in cirrhosis. Gut 2001 49 2 268 275 2-s2.0-0034927835 10.1136/gut.49.2.268 (Pubitemid 32675122)
27. Torregrosa M., Aguadé S., Dos L., Segura R., Gónzalez A., Evangelista A., Castell J., Margarit C., Esteban R., Guardia J., Genescà J., Cardiac alterations in cirrhosis: reversibility after liver transplantation. Journal of Hepatology 2005 42 1 68 74 2-s2.0-19944424108 10.1016/j.jhep.2004. 09.008 (Pubitemid 40038902)
28. Pozzi M., Carugo S., Boari G., Pecci V., De Ceglia S., Maggiolini S., Bolla G. B., Roffi L., Failla M., Grassi G., Giannattasio C., Mancia G., Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997 26 5 1131 1137 2-s2.0-12644271202 (Pubitemid 27509293)
29. Zambruni A., Trevisani F., Caraceni P., Bernardi M., Cardiac electrophysiological abdnormalities in patients with cirrosis. Journal of Hepatology 2006 44 5 994 1002
30. Mandell M. S., Lindenfeld J. A., Tsou M. Y., Zimmerman M., Cardiac evaluation of liver transplant candidates. World Journal of Gastroenterology 2008 14 22 3445 3451 2-s2.0-54349098037 10.3748/wjg.14.3445
31. Sun F. R., Wang Y., Wang B. Y., Tong J., Zhang D., Chang B., Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease. Hepatobiliary and Pancreatic Diseases International 2011 10 1 50 54 2-s2.0-79952044583
32. Bal J. S., Thuluvath P. J., Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver International 2003 23 4 243 248 2-s2.0-0142093013 (Pubitemid 37265799)
33. Umphrey L. G., Hurst R. T., Eleid M. F., Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver trans plantation. Liver transplantation 2008 14 886 892 (Pubitemid 351895519)
34. Harinstein M. E., Flaherty J. D., Ansari A. H., Robin J., Davidson C. J., Rossi J. S., Flamm S. L., Blei A. T., Bonow R. O., Abecassis M., Gheorghiade M., Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. American Journal of Transplantation 2008 8 7 1523 1528 2-s2.0-47249090882 10.1111/j.1600-6143.2008. 02276.x (Pubitemid 351989500)
35. Aaroudi W., Aggarwal H., Igbal F., Heo J., Iskandrian A. E., Left ventricular dyssychrony in patients with LC. Journal of Nuclear Cardiology 2011 18 3 451 455
36. Gazzera C., Roghi D., Valle F., Fifteen years' experience with transjugular intrahepatic portosystemic shunt (TIPS) using bare stents: retrospective review of clinical and technical aspects. Radiology, Medical Imaging 2009 114 1 83 94
37. Kovacs A., Schepke M., Heller J., Short-term effects of trans jugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results. CardioVascular and Intervention al Radiology 2010 33 2 290 296
38. Braverman A. C., Steiner M. A., Picus D., White H., High-output congestive heart failure following transjugular intrahepatic portal-systemic shunting. Chest 1995 107 5 1467 1469 2-s2.0-0029041739
39. Therapondos G., Flapan A. D., Plevris J. N., Hayes P. C., Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transplantation 2005 10 12 1441 1453
40. Snowden C. P., Hughes T., Rose J., Roberts D. R. D., Pulmonary edema in patients after liver transplantation. Liver Transplantation 2000 6 4 466 470 2-s2.0-0033944004 (Pubitemid 30489121)
41. Dec G. W., Kondo N., Farrell M. L., Dienstag J., Cosimi A. B., Semigran M. J., Cardiovascular complications following liver transplantation. Clinical Transplantation 1995 9 6 463 471 2-s2.0-0028879015
42. Rector W. G. Jr, Adair O., Hossack K. F., Rainguet S., Atrial volume in cirrhosis: relationship to blood volume and plasma concentration of atrial natriuretic factor. Gastroenterology 1990 99 3 766 670
43. Wong F., Siu S., Liu P., Blendis L. M., Brain natriuretic peptide: is it a predictor of cardiornyopathy in cirrhosis? Clinical Science 2001 101 6 621 628 2-s2.0-0035215551 10.1042/CS20010183 (Pubitemid 33135343)
44. Henriksen J. H., Gotze J. P., Fuglsang S., Christensen E., Bendtsen F., Moller S., Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 2003 52 10 1511 1517 2-s2.0-0141757412 10.1136/gut.52.10.1511 (Pubitemid 37176734)
45. Pateron D., Beyne P., Laperche T., Elevated circulating cardiac troponin I in patients with cirrhosis. Hepatology 1999 29 3 640 643 (Pubitemid 29109573)
46. Ruiz-Bailén M., Romero-Bermejo F. J., Rucabado-Aguilar L., Pérez-Valenzuela J., Ferrezuelo-Mata Á., Ramírez- Sánchez M., Ramos Cuadra J. A., Martinez Ramírez M. J., Myocardial dysfunction in the critically ill patient: is it really reversible? International Journal of Cardiology 2010 145 3 615 616 2-s2.0-78649922232 10.1016/j.ijcard.2010.09.032
47. Friedrich M. G., Tissue characterization of acute myocardial infarction and myocarditis by cardiac magnetic resonance. Journal of the American College of Cardiology 2008 1 5 652 662 2-s2.0-51649107588 10.1016/j.jcmg.2008.07.011
48. Goitein O., Matetzky S., Beinart R., Di Segni E., Hod H., Bentancur A., Konen E., Acute myocarditis: noninvasive evaluation with cardiac MRI and transthoracic echocardiography. American Journal of Roentgenology 2009 192 1 254 258 2-s2.0-58149267761 10.2214/AJR.08.1281
49. Valeriano V., Funaro S., Lionetti R., Riggio O., Pulcinelli G., Fiore P., Masini A., De Castro S., Merli M., Modification of cardiac function in cirrhotic patients with and without ascites. American Journal of Gastroenterology 2000 95 11 3200 3205 2-s2.0-0033766155 10.1016/S0002-9270(00) 02045-1
50. Abeles R. D., Shawcross D. L., Auzinger G., E/A ratio alone cannot reliably diagnose diastolic dysfunction in the assessment before and after TIPS. Gut 2007 56 11 1642 2-s2.0-35649019162 10.1136/gut.2007.132076
51. Andersen U. B., Moller S., Bendtsen F., Henriksen J. H., Cardiac output determined by echocardiography in patients with cirrhosis: comparison with the indicator dilution technique. European Journal of Gastroenterology & Hepatology 2003 15 5 503 507 (Pubitemid 36571042)
52. Kazankov K., Holland-Fischer P., Andersen N. H., Torp P., Sloth E., Aagaard N. K., Vilstrup H., Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver International 2011 31 4 534 540 2-s2.0-79952480955 10.1111/j.1478-3231.2011.02468.x
53. Moller S., Henriksen J. H., Cirrhotic cardiomyopathy. Journal of Hepatology 2010 53 1 179 190 2-s2.0-77953232095 10.1016/j.jhep.2010.02.023
54. Gaskari S. A., Honar H., Lee S. S., Therapy insight: cirrhotic cardiomyopathy. Nature Clinical Practice Gastroenterology & Hepatology 2006 3 6 329 337 (Pubitemid 43842249)
55. Brilla C. G., Matsubara L. S., Weber K. T., Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. American Journal of Cardiology 1993 71 3 2-s2.0-0027499223
56. Bos R., Mougenot N., indjiL F., Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist. Journal of Cardiovascular Pharmacology 2005 45 8 13 (Pubitemid 40039749)
57. Zambruni A., Trevisani F., Di Micoli A., Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. Journal of Hepatology 2008 48 3 415 421
58. Abraldes J. G., Albillos A., Bañares R., Turnes J., González R., García-Pagán J. C., Bosch J., Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology 2009 136 5 1651 1658 2-s2.0-65349094504 10.1053/j.gastro.2009.01.043
59. Catalina M. V., Barrio J., Anaya F., Salcedo M., Rincón D., Clemente G., Bañares Cañizares R., Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver International 2003 23 3 39 43 2-s2.0-0142063402 (Pubitemid 37264917)
60. Sen S., Mookerjee R. P., Cheshire L. M., Davies N. A., Williams R., Jalan R., Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. Journal of Hepatology 2005 43 1 142 148 2-s2.0-20444413736 10.1016/j.jhep.2005.01.032 (Pubitemid 40805285)
61. Ramsay M., Portopulmonary hypertension and right heart failure in patients with cirrhosis. Current Opinion in Anaesthesiology 2010 23 2 145 150 2-s2.0-77952007671 10.1097/ACO.0b013e32833725c4
62. Robalino B. D., Moodie D. S., Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. Journal of the American College of Cardiology 1991 17 2 492 498 2-s2.0-0025898751
63. Porres-Aguilar M., Zuckerman M. J., Figueroa-Casas J. B., Krowka M. J., Portopulmonary hypertension: state of the art. Annals of Hepatology 2008 7 4 321 330 2-s2.0-56749179184
64. Krowka M. J., Cortese D. A., Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation. Hepatology 1990 11 1 138 142 2-s2.0-0025174385 (Pubitemid 20075114)
65. Swanson K. L., Wiesner R. H., Krowka M. J., Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005 41 5 1122 1129 2-s2.0-17844408122 10.1002/hep.20658 (Pubitemid 40593920)
66. Schenk P., Fuhrmann V., Madl C., Funk G., Lehr S., Kandel O., Müller C., Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002 51 6 853 859 2-s2.0-0036893790 10.1136/gut.51.6.853 (Pubitemid 35408608)
67. Lenci I., Alvior A., Manzia T. M., Saline contrast echocardiography in patients with hepatopulmonary syndrome awaiting liver transplantation. Journal of the American Society of Echocardiography 2009 22 1 89 94
68. Krowka M. J., Dickson E. R., Cortese D. A., Hepatopulmonary syndrome: clinical observations and lack of therapeutic response to somatostatin analogue. Chest 1993 104 2 515 521 2-s2.0-0027257367 (Pubitemid 23229526)
69. Selim K. M., Akriviadis E. A., Zuckerman E., Chen D., Reynolds T. B., Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome. American Journal of Gastroenterology 1998 93 3 455 458 2-s2.0-0032033964 10.1111/j.1572-0241.1998.00455.x (Pubitemid 29068356)
70. Martínez-Pallí G., Drake B. B., García-Pagán J.-C., Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. World Journal of Gastroenterology 2005 11 43 6858 6862 (Pubitemid 43092461)
71. Portal A. J., McPhail M. J., Bruce M., Neutrophil gelatinaseassociated lipocalin predicts acute kidney injury in patients undergoing liver transplantation. Liver Transplantation 2010 16 11 1257 1266
72. Martnllah M., Guevara M., Torre A., Fagundes C., Restuccia T., Gilabert R., Sol E., Pereira G., Marinelli M., Pavesi M., Fernndez J., Rods J., Arroyo V., Gins P., Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011 140 2 488 496 2-s2.0-79251600767 10.1053/j.gastro.2010.07.043
73. Londoño M. C., Guevara M., Rimola A., Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006 130 4 1135 1143
74. Cárdenas A., Ginès P., Acute-on-chronic liver failure: the kidneys. Current Opinion in Critical Care 2011 17 2 184 189 2-s2.0-79953078281 10.1097/MCC.0b013e328344b3da
75. Arroyo V., Ginès P., Gerbes A. L., Dudley F. J., Gentilini P., Laffi G., Reynolds T. B., Ring-Larsen H., Schölmerich J., Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996 23 1 164 176 2-s2.0-0030052899 10.1053/jhep.1996.v23. ajhep0230164 (Pubitemid 26012105)
76. Burton D. R., Bruce A. R., Diagnosis and treatment of hepatorenal syndrome. 2011. Uptodate, 188.81.225.135-A43DB9F193-6.14-177829762
77. Pluta A., Gutkowski K., Hartleb M., Coagulopathy in liver diseases. Advances in Medical Sciences 2010 55 1 16 21 2-s2.0-77954530200 10.2478/v10039-010-0018-3
78. Neeral L. S., Patrick G. N., Stephen H. C., Coagulation abnormalities in patients with liver disease. 2011. Uptodate
79. Jenq C. C., Tsai M. H., Tian Y. C., Chang M. Y., Lin C. Y., Lien J. M., Chen Y. C., Fang J. T., Chen P. C., Yang C. W., Serum sodium predicts prognosis in critically ill cirrhotic patients. Journal of Clinical Gastroenterology 2010 44 3 220 226 2-s2.0-77649284906 10.1097/MCG.0b013e3181aabbcd
80. Liu J. P., Gluud L. L., Als-Nielsen B., Gluud C., Artificial and bioartificial support systems for liver failure. Cochrane Database of Systematic Reviews 2004 1 2-s2.0-2942729640 CD003628
81. Laleman W., Wilmer A., Evenepoel P., Elst I. V., Zeegers M., Zaman Z., Verslype C., Fevery J., Nevens F., Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Critical Care 2006 10 4 2-s2.0-34247550788 10.1186/cc4985 R108 (Pubitemid 47086893)
82. Donati G., Piscaglia F., Colì L., Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis. Alimentary Pharmacology & Therapeutics 2007 26 5 717 726 (Pubitemid 47246207)
83. Dethloff T., Tofteng F., Frederiksen H. J., Hojskov M., Hansen B. A., Larsen F. S., Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled trial study. World Journal of Gastroenterology 2008 14 13 2065 2071 2-s2.0-44849098581 10.3748/wjg.14.2065 (Pubitemid 351795828)
84. Novelli G., Annesini M. C., Morabito V., Cytokine level modifications: molecular adsorbent recirculating system versus standard medical therapy. Transplantation Proceedings 2009 41 4 1243 1248
85. Hassanein T. I., Tofteng F., Brown R. S. Jr, McGuire B., Lynch P., Mehta R., Larsen F. S., Gornbein J., Stange J., Blei A. T., Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007 46 6 1853 1862 2-s2.0-37749045276 10.1002/hep.21930
86. Koivusalo A. M., Teikari T., Höckerstedt K., Isoniemi H., Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy. Metabolic Brain Disease 2008 23 4 387 398 2-s2.0-55149101338 10.1007/s11011-008-9110-9
87. Kuo C., Changchien C., Yang C., Sheen I., Liaw Y., Bacteriemia in patients with cirrhosis of the liver. Liver 1991 11 6 334 339
88. Thulstrup A. M., Sfrensen H., Schfnheyder H., Moller J., Tage-Jansen U., Population-based study of the risk and short-term prognosis for bacteriemia in patients with liver cirrhosis. Clinical Infectious Diseases 2000 31 6 1357 1361 10.1086/317494
89. Arvaniti V., D'Amico G., Fede G., Manousou P., Tsochatzis E., Pleguezuelo M., Burroughs A. K., Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010 139 4 1246 e5 2-s2.0-77957327198 10.1053/j.gastro.2010.06.019
90. Tandon P., Garcia-Tsao G., Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Seminars in Liver Disease 2008 28 1 26 42 2-s2.0-40149099357 10.1055/s-2008-1040319 (Pubitemid 351326531)
91. Johnson D. H., Cunha B. A., Infections in cirrhosis. Infectious Disease Clinics of North America 2001 15 2 363 371 2-s2.0-0034953648 (Pubitemid 32606904)
92. Zimmermann H. W., Seidler S., Gassler N., Nattermann J., Luedde T., Trautwein C., Tacke F., Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS ONE 2011 6 6 2-s2.0-79959382649 10.1371/journal.pone. 0021381 e21381
93. Chavez-Tapia N. C., Soares-Weiser K., Brezis M., Leibovici L., Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients. Cochrane Database of Systematic Reviews 2009 1 2-s2.0-70249145422 10.1002/14651858.CD002232.pub2 CD002232
94. Foreman M. G., Mannino D. M., Moss M., Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 2003 124 3 1016 1020 2-s2.0-0141465224 10.1378/chest.124.3.1016 (Pubitemid 37123324)
95. TenHoor T., Mannino D. M., Moss M., Risk factors for ARDS in the United States: analysis of the 1993 national mortality followback study. Chest 2001 119 4 1179 1184 2-s2.0-0034912518 10.1378/chest.119.4.1179 (Pubitemid 32679448)
96. Viasus D., Garcia-Vidal C., Castellote J., Adamuz J., Verdaguer R., Dorca J., Manresa F., Gudiol F., Carratalà J., Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine 2011 90 2 110 118 2-s2.0-79952448437 10.1097/MD.0b013e318210504c
97. Kim B. I., Kim H. J., Park J. H., Park D. I., Cho Y. K., Sohn C. I., Jeon W. K., Kim H. S., Kim D. J., Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage. Journal of Gastroenterology and Hepatology 2011 26 3 550 557 2-s2.0-79951632536 10.1111/j.1440-1746.2010.06490.x
98. Kang C. I., Song J. H., Chung D. R., Liver cirrhosis as a risk factor for mortality in a national cohort of patients with bacteremia. Journal of Infection 2011 63 5 336 343
99. Filloux B., Chagneau-Derrode C., Ragot S., Short-term and long-term vital outcomes of cirrhotic patients admitted to an intensive care unit. European Journal of Gastroenterology & Hepatology 2010 22 12 1474 1480
100. Levesque E., Hoti E., Azoulay D., Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. Journal of Hepatology 2012 56 1 95 102
101. Feltracco P., Brezzi M., Barbieri S., Milevoj M., Galligioni H., Cillo U., Zanus G., Vitale A., Ori C., Intensive care unit admission of decompensated cirrhotic patients: prognostic scoring systems. Transplantation Proceedings 2011 43 4 1079 1084 2-s2.0-79957589557 10.1016/j.transproceed.2011.01.153
102. Vincent J. L., Rhodes A., Perel A., Clinical review: update on hemodynamic monitoringa consensus of 16. Critical Care 2011 15 4 229